Greater Manchester Medicines Management Group

images courtesy of NHS Photo Library

NHS logo

Formulary Subgroup - BNF Chapters

The GMMMG formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. Adherence to the formulary is strongly recommended by GMMMG and this formulary supersedes all local formularies.  The formulary is applicable to new initiations and should meet the needs of the majority of adult patients.

NICE approved medicines:
All medicines recommended for use in the NHS in a NICE Technology Assessment are approved for use in Greater Manchester.

The documents on this page will be subject to updates. Please refresh your browser to ensure that you are looking at the latest versions. If you have any requests, changes or removals please go to the Formulary Requests section.

At the start of each chapter the contents section hyperlinks to the various subsections within that chapter.


The GM Formulary includes medicines and technologies for use in adult patients only. For information relating to prescribing in children prescribers should refer to the BNF and BNFc.

The GMMMG Formulary lists products by generic drug name. For some drugs, branded generics may offer a more economical means of procurement in Primary Care. In this instance the brand with the lowest acquisition cost and greatest ease of acquisition should be prescribed according to local choice.

spacer

spacer

Chapter

Last
Updated

Chapter Status

1

Gastro–intestinal system

11/03/2020

Final version 5.11

2

Cardiovascular system

28/09/2020

Final version 5.12

3

Respiratory system

11/03/2020

Final version 5.11

4

Central nervous system

21/10/2020

Final version 7.4

5

Infections

11/03/2020

Final version 5.6

6

Endocrine system

20/07/2020

Final version 7.22

7

Obstetrics, gynaecology and urinary–tract disorders

28/09/2020

Final version 6.13

8

Malignant disease and immunosuppression

28/09/2020

Final version 10.9

9

Nutrition and blood

13/07/2020

Final version 4.8

10

Musculoskeletal and joint diseases

30/01/2020

Final version 5.8

11

Eye

28/09/2020

Final version 4.9

12

Ear, nose and oropharynx

Nov 2019

Final version 4.4

13

Skin

21/07/2020

Final version 4.17

14

Immunological products and vaccines

on hold

on hold

15

Anaesthesia

on hold

on hold

GM formulary change log

28/09/2020

Wound Care
Wound Care - complete


13/10/2020


Version 3.0

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer